Evaluation of the CloSys Closure System as an Adjunct to Standard Compression
Not Applicable
Terminated
- Conditions
- Sealing the Arteriotomy
- Registration Number
- NCT00963690
- Lead Sponsor
- CloSys Corporation
- Brief Summary
The purpose of this study is to evaluate the safety and efficacy of the CloSys Hemostatic Device designed to stop bleeding after an interventional procedure.
- Detailed Description
To analyze the time to hemostasis (time to stop bleeding), time to ambulation (time to walk) and adverse events.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Time to hemostasis 1 Hour Time to ambulation 6 Hours
- Secondary Outcome Measures
Name Time Method Adverse events Within 30 days after procedure
Trial Locations
- Locations (2)
Cardiovascular Institute of the South
🇺🇸Lafayette, Louisiana, United States
Rex Healthcare - Rex Heart and Vascular Research
🇺🇸Raleigh, North Carolina, United States
Cardiovascular Institute of the South🇺🇸Lafayette, Louisiana, United States